Nitric oxide synthase inhibition and platelet function.
Bodzenta-Lukaszyk
A
A
Department of Gastroenterology, Medical School, Białystok, Poland.
Gabryelewicz
A
A
Lukaszyk
A
A
Bielawiec
M
M
Konturek
J W
JW
Domschke
W
W
D000328:Adult; D000594:Amino Acid Oxidoreductases / Q000037:antagonists & inhibitors*; D001120:Arginine / Q000031:analogs & derivatives* / Q000494:pharmacology; D001792:Blood Platelets / Q000378:metabolism; D006801:Humans; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase; D015539:Platelet Activation / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count / Q000187:drug effects; D010978:Platelet Factor 4 / Q000032:analysis; D001620:beta-Thromboglobulin / Q000032:analysis; D019323:omega-N-Methylarginine
D001620:beta-Thromboglobulin; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D010978:Platelet Factor 4; D001120:Arginine; D019001:Nitric Oxide Synthase; D000594:Amino Acid Oxidoreductases